They would have to, however, I know nothing about Cure beyond the fact that they manufacture products from many companies. It seems likely they will be doing the manufacturing of any Fuse products. However, they seem to be a factory, not so involved on the research side of things. Please let me know if this is incorrect.
I believe I have stated that it would be in Fuse's best interest to license out whatever they have to a pharma. The reasons drugs are so expensive is because pharma companies break the bank developing these things, and then only get to sell them for a couple years before they are allowed to go generic. They have to recoup their expenses in a relatively short time. So, yes, Fuse avoids manufacturing costs, but unfortunately that is not where the majority of expenses lie.
As always, I may be, and hope I am, underestimating the progress Fuse has made.
Market Data 
Markets 
AI
